 TEL AVIV, Israel and BETHESDA, Md., Oct. 18, 2021 PRNewswire -- Cannabics Pharmaceuticals Inc. OTC: CNBX, a global leader in the development of cancer related cannabinoid-based medicine, announced today that it has filed 2 new Provisional Patent applications on Compositions and Methods for treating cancer, including colorectal cancer and early intervention therapy for colorectal cancer patients. 